Tositumomab (
Bexxar®) is a prescription medication approved to treat certain types of non-
Hodgkin's lymphoma (cancer of the lymphatic system). It is specifically designed for use in people whose cancer has returned or for those who have failed to respond to other treatments.
Tositumomab is a monoclonal antibody. As part of the tositumomab treatment regimen, the antibody is linked to a radioactive element (Iodine I-131). Radioactive treatment such as this is sometimes called radioimmunotherapy.
Zevalin® (
ibritumomab) is another example of radioimmunotherapy used to treat non-Hodgkin's lymphoma.
Just like any medicine, tositumomab can cause side effects, some of which can be significant.
Although not everyone who receives this medicine will have problems, most people will experience some type of adverse reaction to this drug.
Talk to your healthcare provider about strategies to prevent or treat side effects you may experience. He or she may give you medicines to help manage some of the reactions caused by this drug.
Common side effects of tositumomab include but are not limited to:
- Low blood cell counts
- Infection
- Lack of strength or weakness
- Fever
- Nausea.
(Click Tositumomab Side Effects to learn more, including potentially serious side effects you should report immediately to your healthcare provider.)
HealthSavvy Sign In
|
